The AREXIS brand, founded in 2005 (Sweden), from 28 sister brands and 4958 competing brands. The AREXIS brand is owned by Swedish Orphan Bio, a company listed in Francfort. The International Securities Identification Number (ISIN) of Swedish Orphan Bio is SE0000872095. AREXIS belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
Swedish Orphan Bio
(AREXIS)
over 5 years*
EUR 13.67